Sample Elution
Sample Elution - Related Videos
03:41
DFE-Based Affinity Chromatography: A Technique for Purification of 2F5 Monoclonal Antibodies from a Crude Sample Using High Ionic Strength-Based Elution Conditions
0 Views •
2025
This video describes an affinity chromatography technique for purifying 2F5 monoclonal antibodies using the DsRed-2F5-Epitope or DFE ligands. The purified 2F5 monoclonal antibodies are essential drugs in immunotherapy.
01:05
High-Performance Liquid Chromatography: Elution Process
0 Views •
2024
In High-Performance Liquid Chromatography (HPLC), the elution process is critical to the separation of analytes and the quality of chromatographic results. Elution describes how compounds move through the column and separate based on their interactions with the mobile and stationary phases. This process determines the resolution, peak shape, and retention times in the chromatogram, which are essential for identifying and quantifying components in complex mixtures. Understanding the elution...
11:38
CN-GELFrEE - Clear Native Gel-eluted Liquid Fraction Entrapment Electrophoresis
0 Views •
Cited by 11 •
2016
This protocol describes how to prepare and perform clear native gel-eluted liquid fraction entrapment electrophoresis (CN-GELFrEE), a native separation technique for non-covalent biomolecular assemblies and proteins from heterogeneous samples that is compatible with various downstream protein analysis techniques.
06:18
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
0 Views •
Cited by 5 •
2023
Here, we present a protocol to evaluate the antibacterial efficacy of an antibiotic-eluting polymer to simulate prophylactic clinical application by using a commercially available real-time ATP-based luminescent microbial viability assay. This method enables the monitoring of the longitudinal activity of drug-eluting materials and can be widely adapted to test anti-microbial drug delivery platforms.
08:26
Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
0 Views •
Cited by 13 •
2020
Laryngotracheal stenosis results from pathologic scar deposition that critically narrows the tracheal airway and lacks effective medical therapies. Using a PLLA-PCL (70% poly-L-lactide and 30% polycaprolactone) stent as a local drug delivery system, potential therapies aimed at decreasing scar proliferation in the trachea can be studied.
FAQs
Recovery depends on how effectively the selected solvent or buffer weakens the interactions holding the target substance within the solid or immobilized matrix. A suitable liquid allows the analyte to dissolve and transfer into the collected eluate rather than remaining associated with the matrix. This choice directly affects how much clinically relevant material becomes available for downstream analysis.
The matrix determines how strongly the target substance is retained and therefore influences its release into the liquid phase. Extraction columns, membranes, and dried specimens can each present different retention conditions. Selecting an elution liquid suited to the matrix helps improve analyte recovery and produces an eluate that is more useful for subsequent chromatography, immunoassays, or molecular testing.
Successful recovery requires both sufficient disruption of analyte-to-matrix interactions and adequate dissolution of the target substance in the applied liquid. If those conditions are not met, material may remain in the matrix and become unavailable for testing. When they are appropriate, the collected eluate provides better access to biomarkers, pharmaceuticals, proteins, or nucleic acids.
The workflow begins with a solid or immobilized sample matrix, followed by application of a selected solvent or buffer. The liquid phase is then collected as the eluate, which carries the released target substances. That eluate proceeds to an analytical method such as chromatography, an immunoassay, or molecular testing, depending on the information required.
Sample Elution can be applied to materials that hold target substances in a solid or immobilized form. The provided examples include extraction columns, membranes, and dried specimens. These formats allow recovery of biomarkers, pharmaceuticals, proteins, or nucleic acids into a liquid eluate, making otherwise retained material accessible to analytical procedures used in research and medicine.
In medicine, the technique makes clinically relevant substances available for measurement after they have been retained in a sample matrix. The resulting eluate may contain biomarkers, pharmaceuticals, proteins, or nucleic acids and can be analyzed by chromatography, immunoassays, or molecular testing. Those results can support diagnosis, monitoring, and medical research by providing access to target analytes.